Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

COVID-19

Free Subscription Articles published in Intensive Care Med Retrieve available abstracts of 116 articles: HTML format

Single Articles

July 2025
1. VAIDIE J, Demiselle J, Gabriel A, Guillon A, et al
   Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically Ill patients with solid organ transplant: a retrospective multicenter study.
   Intensive Care Med. 2025 Jul 16. doi: 10.1007/s00134-025-08024.
   PubMed     Abstract available
   
   
   May 2025
2. CARLET J, Payen D, Singer M
   A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.
   Intensive Care Med. 2025 May 23. doi: 10.1007/s00134-025-07878.
   PubMed    
   
   
   April 2025
3. ESPERATTI M, Fuentes N, Olmos M
   Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance. Author's reply.
   Intensive Care Med. 2025 Apr 29. doi: 10.1007/s00134-025-07904.
   PubMed    
   
   
   
4. PETTENUZZO T, Balzani E, Sella N, Giani M, et al
   Prone positioning during veno-venous extracorporeal membrane oxygenation: a systematic review and meta-analysis.
   Intensive Care Med. 2025 Apr 29. doi: 10.1007/s00134-025-07877.
   PubMed     Abstract available
   
   
   
5. BOERS LS, van Someren Greve F, van Hattem JM, de Brabander J, et al
   Correction: Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
   Intensive Care Med. 2025 Apr 14. doi: 10.1007/s00134-025-07854.
   PubMed    
   
   
   March 2025
6. BIHLMAIER K, Willam C, Herbst L, Hackstein H, et al
   Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS).
   Intensive Care Med. 2025 Mar 26. doi: 10.1007/s00134-025-07863.
   PubMed    
   
   
   
7. CHEN B, Li S
   Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance.
   Intensive Care Med. 2025 Mar 17. doi: 10.1007/s00134-025-07860.
   PubMed    
   
   
   February 2025
8. OLMOS M, Fuentes N, Busico M, Gallardo A, et al
   Effectiveness of bundle of care on tolerance of awake-prone positioning in patients with acute respiratory failure. A multicenter observational study.
   Intensive Care Med. 2025 Feb 17. doi: 10.1007/s00134-025-07804.
   PubMed     Abstract available
   
   
   
9. ROWLAND A, Boulanger C, Dalton L
   Supporting the bereaved child in the adult ICU: a narrative review.
   Intensive Care Med. 2025 Feb 12. doi: 10.1007/s00134-025-07813.
   PubMed     Abstract available
   
   
   November 2024
10. LIU L, Sun Q, Yang Y, Qiu H, et al
    Individualized response to awake prone positioning in COVID-19 patients: need deeper insights.
    Intensive Care Med. 2024 Nov 20. doi: 10.1007/s00134-024-07729.
    PubMed    
    
    
    
11. OLMOS M, Esperatti M, Fuentes N, Miranda Tirado A, et al
    Early physiologic changes after awake prone positioning predict clinical outcomes in patients with acute hypoxemic respiratory failure.
    Intensive Care Med. 2024 Nov 14. doi: 10.1007/s00134-024-07690.
    PubMed     Abstract available
    
    
    
12. WANG Y, Hao S, Song J, Zhong M, et al
    Reflections on awake prone positioning in COVID-19: considerations on body inclination, respiratory support, and patient variability.
    Intensive Care Med. 2024 Nov 4. doi: 10.1007/s00134-024-07710.
    PubMed    
    
    
    October 2024
13. LIU L, Sun Q, Yang Y, Qiu H, et al
    Prolonged versus shorter awake prone positioning in COVID-19: clinical outcomes and future implications.
    Intensive Care Med. 2024 Oct 17. doi: 10.1007/s00134-024-07675.
    PubMed    
    
    
    
14. BOERS LS, van Someren Greve F, van Hattem JM, Schinkel J, et al
    Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective. Author's reply.
    Intensive Care Med. 2024 Oct 9. doi: 10.1007/s00134-024-07671.
    PubMed    
    
    
    
15. KESECIOGLU J, Rusinova K, Alampi D, Arabi YM, et al
    European Society of Intensive Care Medicine guidelines on end of life and palliative care in the intensive care unit.
    Intensive Care Med. 2024 Oct 3. doi: 10.1007/s00134-024-07579.
    PubMed     Abstract available
    
    
    
16. MUNSHI L, Dumas G, Mehta S
    Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic? Author's reply.
    Intensive Care Med. 2024 Oct 1. doi: 10.1007/s00134-024-07614.
    PubMed    
    
    
    September 2024
17. CECCONI M, Barth A, Szollosi GJ, Istrate GM, et al
    The impact of the massive open online course C19_SPACE during the COVID-19 pandemic on clinical knowledge enhancement: a study among medical doctors and nurses.
    Intensive Care Med. 2024 Sep 30. doi: 10.1007/s00134-024-07652.
    PubMed     Abstract available
    
    
    
18. LEI R, Yue C, Li R, Zhao K, et al
    Prolonged awake prone positioning in COVID-19: recommendations and outlook.
    Intensive Care Med. 2024 Sep 16. doi: 10.1007/s00134-024-07640.
    PubMed    
    
    
    
19. YOUNG PJ
    Less is best for oxygen therapy in adults in the intensive care unit with severe hypoxaemia due to COVID-19.
    Intensive Care Med. 2024 Sep 12. doi: 10.1007/s00134-024-07554.
    PubMed    
    
    
    
20. AZOULAY E, Zuber J, Bousfiha AA, Long Y, et al
    Complement system activation: bridging physiology, pathophysiology, and therapy.
    Intensive Care Med. 2024 Sep 10. doi: 10.1007/s00134-024-07611.
    PubMed     Abstract available
    
    
    
21. CRESCIOLI E, Nielsen FM, Bunzel AM, Eriksen ASB, et al
    Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia.
    Intensive Care Med. 2024 Sep 5. doi: 10.1007/s00134-024-07613.
    PubMed     Abstract available
    
    
    
22. ZENG G, Wang L
    Awake prone positioning for COVID-19 patients with acute respiratory failure: unknown appropriate duration.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07637.
    PubMed    
    
    
    
23. SUNDARAM T, Sathishkumar K
    Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07636.
    PubMed    
    
    
    
24. SATHISHKUMAR K
    Comparative efficacy of prolonged versus shorter awake prone positioning in managing acute respiratory failure in COVID-19 Patients. A Clinical Assessment.
    Intensive Care Med. 2024 Sep 2. doi: 10.1007/s00134-024-07621.
    PubMed    
    
    
    August 2024
25. BRUSE N, Motos A, van Amstel R, de Bie E, et al
    Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients.
    Intensive Care Med. 2024 Aug 26. doi: 10.1007/s00134-024-07593.
    PubMed     Abstract available
    
    
    
26. COSTA-PINTO R, Bellomo R
    COVID-19-associated pulmonary aspergillosis - we should take an individualised approach with early treatment too.
    Intensive Care Med. 2024 Aug 12. doi: 10.1007/s00134-024-07583.
    PubMed    
    
    
    
27. LIU L, Sun Q, Zhao H, Liu W, et al
    Prolonged vs shorter awake prone positioning for COVID-19 patients with acute respiratory failure: a multicenter, randomised controlled trial.
    Intensive Care Med. 2024 Aug 1. doi: 10.1007/s00134-024-07545.
    PubMed     Abstract available
    
    
    July 2024
28. LUYT CE, Girardis M, Paixao P
    Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question.
    Intensive Care Med. 2024 Jul 24. doi: 10.1007/s00134-024-07562.
    PubMed    
    
    
    
29. BOERS LS, van Someren Greve F, van Hattem JM, de Brabander J, et al
    Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19.
    Intensive Care Med. 2024 Jul 17. doi: 10.1007/s00134-024-07529.
    PubMed     Abstract available
    
    
    
30. NIELSEN FM, Klitgaard TL, Bruun NH, Moller MH, et al
    Lower or higher oxygenation targets in the intensive care unit: an individual patient data meta-analysis.
    Intensive Care Med. 2024 Jul 11. doi: 10.1007/s00134-024-07523.
    PubMed     Abstract available
    
    
    
31. PRATTES J, Giacobbe DR, Bassetti M, Gangneux JP, et al
    Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.
    Intensive Care Med. 2024 Jul 9. doi: 10.1007/s00134-024-07542.
    PubMed    
    
    
    
32. SHARSHAR T
    The paradox of post-intensive care unit physical therapy.
    Intensive Care Med. 2024 Jul 9. doi: 10.1007/s00134-024-07539.
    PubMed    
    
    
    
33. SHARSHAR T, Sonneville R, Quenot JP
    Seeking the road to healing after intensive care unit: we need a personalised global positioning system.
    Intensive Care Med. 2024 Jul 3. doi: 10.1007/s00134-024-07535.
    PubMed    
    
    
    June 2024
34. SHARSHAR T
    Post-intensive care unit care: it is time to abandon hospital-centrism.
    Intensive Care Med. 2024 Jun 27. doi: 10.1007/s00134-024-07527.
    PubMed    
    
    
    
35. APPIAH JA, Barth A, McGloughlin S, Cecconi M, et al
    Global impact: WHO and ESICM collaboration in launching the COVID-19 skills preparation course.
    Intensive Care Med. 2024 Jun 25. doi: 10.1007/s00134-024-07469.
    PubMed    
    
    
    May 2024
36. OUD L
    Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic?
    Intensive Care Med. 2024 May 28. doi: 10.1007/s00134-024-07493.
    PubMed    
    
    
    
37. ROUSSEAU AF, Minguet P, Neis-Gilson S, Misset B, et al
    Post-intensive care unit follow-up: don't stop it now!
    Intensive Care Med. 2024 May 7. doi: 10.1007/s00134-024-07467.
    PubMed    
    
    
    
38. DE CORTE T, Kohler K, Cecconi M, De Waele JJ, et al
    Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic.
    Intensive Care Med. 2024 May 6. doi: 10.1007/s00134-024-07444.
    PubMed    
    
    
    
39. CHEUNG EH, Ho L
    Seeking the road to healing: unanswered questions in the role of post-intensive care multidisciplinary consultations.
    Intensive Care Med. 2024 May 6. doi: 10.1007/s00134-024-07461.
    PubMed    
    
    
    
40. MONTOMOLI J, Vergano M, Semeraro F, Bignami EG, et al
    From the pandemic to a war: a call for solidarity with all healthcare workers.
    Intensive Care Med. 2024;50:776-777.
    PubMed    
    
    
    March 2024
41. AZOULAY E, Resche-Rigon M, Pochard F, Souppart V, et al
    One-year outcomes in acute respiratory distress syndrome survivors: COVID-19 versus seasonal influenza or pneumonia.
    Intensive Care Med. 2024 Mar 27. doi: 10.1007/s00134-024-07396.
    PubMed    
    
    
    
42. SALVE G, Mongodi S, Mangiagalli M, Tintim Lobato C, et al
    Memories of ICU stay in patients admitted for severe COVID-19.
    Intensive Care Med. 2024 Mar 4. doi: 10.1007/s00134-024-07365.
    PubMed    
    
    
    February 2024
43. FERNANDO SM, Brodie D, Barbaro RP, Agerstrand C, et al
    Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry.
    Intensive Care Med. 2024 Feb 20. doi: 10.1007/s00134-024-07343.
    PubMed     Abstract available
    
    
    November 2023
44. GRANTON J, Novitzky-Basso IN, Binnie A, Mattsson J, et al
    Decidual stromal cells for the treatment of severe COVID-19 ARDS.
    Intensive Care Med. 2023 Nov 15. doi: 10.1007/s00134-023-07262.
    PubMed    
    
    
    October 2023
45. HOFFMANN M, Jeitziner MM, Riedl R, Mueller G, et al
    Effects of an online information tool on post-traumatic stress disorder in relatives of intensive care unit patients: a multicenter double-blind, randomized, placebo-controlled trial (ICU-Families-Study).
    Intensive Care Med. 2023 Oct 23. doi: 10.1007/s00134-023-07215.
    PubMed     Abstract available
    
    
    September 2023
46. DECLERCQ PL, Fournel I, Demeyere M, Berraies A, et al
    Correction: Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
    Intensive Care Med. 2023 Sep 27. doi: 10.1007/s00134-023-07217.
    PubMed    
    
    
    
47. MCPEAKE J, Castro P, Kentish-Barnes N, Cuzco C, et al
    Post-hospital recovery trajectories of family members of critically ill COVID-19 survivors: an international qualitative investigation.
    Intensive Care Med. 2023 Sep 12. doi: 10.1007/s00134-023-07202.
    PubMed     Abstract available
    
    
    August 2023
48. OPPERHUIZEN AL, van Lier IMJ, Hartmeyer SL, Aarts MPJ, et al
    Effectiveness of blue light-emitting glasses for intensive care unit health care workers on night shifts during the COVID-19 pandemic.
    Intensive Care Med. 2023 Aug 30. doi: 10.1007/s00134-023-07175.
    PubMed    
    
    
    
49. DECLERCQ PL, Fournel I, Demeyere M, Berraies A, et al
    Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study.
    Intensive Care Med. 2023 Aug 24. doi: 10.1007/s00134-023-07180.
    PubMed     Abstract available
    
    
    
50. SHEPHERD JM, Ross J, Anton L, Rourke C, et al
    Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.
    Intensive Care Med. 2023;49:922-933.
    PubMed     Abstract available
    
    
    July 2023
51. ARABI YM, Diaz J, Lamontagne F
    Coronavirus disease 2019.
    Intensive Care Med. 2023 Jul 28. doi: 10.1007/s00134-023-07168.
    PubMed    
    
    
    
52. GALLI F, Bindo F, Motos A, Fernandez-Barat L, et al
    Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
    Intensive Care Med. 2023 Jul 28. doi: 10.1007/s00134-023-07161.
    PubMed     Abstract available
    
    
    
53. HUANG S, Vieillard-Baron A, Evrard B, Prat G, et al
    Echocardiography phenotypes of right ventricular involvement in COVID-19 ARDS patients and ICU mortality: post-hoc (exploratory) analysis of repeated data from the ECHO-COVID study.
    Intensive Care Med. 2023 Jul 12. doi: 10.1007/s00134-023-07147.
    PubMed     Abstract available
    
    
    June 2023
54. GRASSELLI G, Calfee CS, Camporota L, Poole D, et al
    ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.
    Intensive Care Med. 2023 Jun 16. doi: 10.1007/s00134-023-07050.
    PubMed     Abstract available
    
    
    
55. KREITMANN L, Jermoumi S, Vasseur M, Chabani M, et al
    Relationship between COVID-19 and ICU-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter before-after study.
    Intensive Care Med. 2023 Jun 16. doi: 10.1007/s00134-023-07109.
    PubMed     Abstract available
    
    
    May 2023
56. BRADBURY CA, Lawler PR, McVerry BJ, Zarychanski R, et al
    Continuation of therapeutic dose heparin for critically ill patients with COVID-19.
    Intensive Care Med. 2023 May 31:1-3. doi: 10.1007/s00134-023-07095.
    PubMed    
    
    
    
57. ROQUILLY A, Francois B, Huet O, Launey Y, et al
    Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial.
    Intensive Care Med. 2023;49:530-544.
    PubMed     Abstract available
    
    
    April 2023
58. 
    Variants of concern and clinical outcomes in critically ill COVID-19 patients.
    Intensive Care Med. 2023 Apr 17:1-3. doi: 10.1007/s00134-023-07039.
    PubMed    
    
    
    
59. HEESAKKERS H, van der Hoeven JG, van den Boogaard M, Zegers M, et al
    Two-year physical, mental and cognitive outcomes among intensive care unit survivors treated for COVID-19.
    Intensive Care Med. 2023 Apr 5:1-3. doi: 10.1007/s00134-023-07038.
    PubMed    
    
    
    
60. MARTIN-LOECHES I, Torres A, Nagavci B, Aliberti S, et al
    ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.
    Intensive Care Med. 2023 Apr 4:1-18. doi: 10.1007/s00134-023-07033.
    PubMed     Abstract available
    
    
    March 2023
61. NAENDRUP JH, Steinke J, Grans-Siebel J, Koehler P, et al
    COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula.
    Intensive Care Med. 2023 Mar 28:1-3. doi: 10.1007/s00134-023-07040.
    PubMed    
    
    
    
62. PAPAZIAN L, Hraiech S, Loundou A, Herridge MS, et al
    High-level burnout in physicians and nurses working in adult ICUs: a systematic review and meta-analysis.
    Intensive Care Med. 2023 Mar 27:1-14. doi: 10.1007/s00134-023-07025.
    PubMed     Abstract available
    
    
    
63. JANSSEN M, Endeman H, Bos LDJ
    Targeted immunomodulation: a primer for intensivists.
    Intensive Care Med. 2023 Mar 3. doi: 10.1007/s00134-023-07009.
    PubMed    
    
    
    February 2023
64. DUCLOS A, Cordier Q, Polazzi S, Colin C, et al
    Excess mortality among non-COVID-19 surgical patients attributable to the exposure of French intensive and intermediate care units to the pandemic.
    Intensive Care Med. 2023 Feb 25:1-11. doi: 10.1007/s00134-023-07000.
    PubMed     Abstract available
    
    
    
65. ARABI YM, Al-Dorzi HM, Aldekhyl S, Al Qahtani S, et al
    Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial.
    Intensive Care Med. 2023 Feb 23:1-11. doi: 10.1007/s00134-023-06981.
    PubMed     Abstract available
    
    
    January 2023
66. GONZALEZ J, Benitez ID, Motos A, Torres A, et al
    Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation.
    Intensive Care Med. 2023 Jan 25:1-4. doi: 10.1007/s00134-022-06951.
    PubMed    
    
    
    
67. FINAZZI S, Perego M, Tricella G, Poole D, et al
    SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure.
    Intensive Care Med. 2023 Jan 25:1-3. doi: 10.1007/s00134-022-06952.
    PubMed    
    
    
    
68. NOVA A, Rezoagli E, Eronia N, Foti G, et al
    Role of PEEP on the prognostic performance of the ROX index in hypoxemic respiratory failure due to COVID-19: any further gain in outcome prediction?
    Intensive Care Med. 2023 Jan 10. doi: 10.1007/s00134-022-06965.
    PubMed    
    
    
    
69. ROSA RG, Cavalcanti AB, Azevedo LCP, Veiga VC, et al
    Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study.
    Intensive Care Med. 2023 Jan 3:1-12. doi: 10.1007/s00134-022-06953.
    PubMed     Abstract available
    
    
    
70. MOMBRUN M, Marliot C, Jurj AA, Ramakers M, et al
    Massive gaseous embolism during cardiopulmonary resuscitation for massive hemoptysis in a COVID-19-associated pulmonary aspergillosis.
    Intensive Care Med. 2023 Jan 2:1-2. doi: 10.1007/s00134-022-06960.
    PubMed    
    
    
    December 2022
71. MCNICHOLAS BA, Ehrmann S, Laffey JG
    Awake prone positioning.
    Intensive Care Med. 2022;48:1793-1795.
    PubMed    
    
    
    November 2022
72. CHEAN D, Benarroch S, Pochard F, Kentish-Barnes N, et al
    Mental health symptoms are not correlated with peripheral inflammatory biomarkers concentrations in COVID-19-ARDS survivors.
    Intensive Care Med. 2022 Nov 30:1-3. doi: 10.1007/s00134-022-06936.
    PubMed    
    
    
    
73. OHBE H, Goto T, Okada A, Yasunaga H, et al
    Association between COVID-19 pandemic and mental disorders in spouses of intensive care unit patients.
    Intensive Care Med. 2022 Nov 29:1-3. doi: 10.1007/s00134-022-06941.
    PubMed    
    
    
    
74. BROCHHAUSEN C, Bein T, Fineschi V
    Close collaboration between pathologists and intensivists to understand (not just) coronavirus disease.
    Intensive Care Med. 2022 Nov 2. pii: 10.1007/s00134-022-06917.
    PubMed    
    
    
    October 2022
75. COLAIANNI-ALFONSO N, Montiel GC, Castro-Sayat M, Roca O, et al
    ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19.
    Intensive Care Med. 2022 Oct 21. pii: 10.1007/s00134-022-06913.
    PubMed    
    
    
    
76. BAKKERUS L, Pickkers P
    Personalized medicine in COVID-19.
    Intensive Care Med. 2022 Oct 10. pii: 10.1007/s00134-022-06908.
    PubMed    
    
    
    September 2022
77. KWON KE, Jung SY, Baek MS, Kim WY, et al
    Corticosteroids in H1N1, non-viral, and COVID-19 ARDS.
    Intensive Care Med. 2022 Sep 29. pii: 10.1007/s00134-022-06891.
    PubMed    
    
    
    
78. FISH M, Rynne J, Jennings A, Lam C, et al
    Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06869.
    PubMed     Abstract available
    
    
    
79. MEHTA P, Rosas IO, Singer M
    Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity.
    Intensive Care Med. 2022 Sep 8. pii: 10.1007/s00134-022-06877.
    PubMed    
    
    
    August 2022
80. BOUSSARSAR M, Protti A
    Pulmonary air leak in COVID-19: time to learn from our mistakes.
    Intensive Care Med. 2022 Aug 20. pii: 10.1007/s00134-022-06866.
    PubMed    
    
    
    
81. RICCI Z, Romagnoli S, Reis T, Bellomo R, et al
    Hemoperfusion in the intensive care unit.
    Intensive Care Med. 2022 Aug 19. pii: 10.1007/s00134-022-06810.
    PubMed     Abstract available
    
    
    
82. PEJU E, Belicard F, Silva S, Hraiech S, et al
    Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study.
    Intensive Care Med. 2022 Aug 17. pii: 10.1007/s00134-022-06833.
    PubMed     Abstract available
    
    
    
83. SUPADY A, Combes A, Barbaro RP, Camporota L, et al
    Respiratory indications for ECMO: focus on COVID-19.
    Intensive Care Med. 2022 Aug 9. pii: 10.1007/s00134-022-06815.
    PubMed     Abstract available
    
    
    
84. GEBHARD CE, Hamouda N, Gebert P, Regitz-Zagrosek V, et al
    Sex versus gender-related characteristics: which predicts clinical outcomes of acute COVID-19?
    Intensive Care Med. 2022 Aug 9. pii: 10.1007/s00134-022-06836.
    PubMed    
    
    
    
85. KNOX DB, Brunhoeber A, Peltan ID, Brown SM, et al
    Comparison of radiographic pneumothorax and pneumomediastinum in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome.
    Intensive Care Med. 2022 Aug 5. pii: 10.1007/s00134-022-06816.
    PubMed    
    
    
    
86. ROSE L, Cook A, Onwumere J, Terblanche E, et al
    Psychological distress and morbidity of family members experiencing virtual visiting in intensive care during COVID-19: an observational cohort study.
    Intensive Care Med. 2022 Aug 1. pii: 10.1007/s00134-022-06824.
    PubMed     Abstract available
    
    
    July 2022
87. MANSOUR A, Flecher E, Schmidt M, Rozec B, et al
    Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.
    Intensive Care Med. 2022 Jul 13. pii: 10.1007/s00134-022-06794.
    PubMed     Abstract available
    
    
    
88. TALLARICO RT, Deniau B, Fong N, Ghosn J, et al
    Differences in HADS and SF-36 scores 1 year after critical illness in COVID-19 patients.
    Intensive Care Med. 2022 Jul 8. pii: 10.1007/s00134-022-06797.
    PubMed    
    
    
    
89. GRECO M, De Corte T, Ercole A, Antonelli M, et al
    Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study.
    Intensive Care Med. 2022 Jul 7. pii: 10.1007/s00134-022-06801.
    PubMed    
    
    
    June 2022
90. ANNANE D, Meduri GU
    Precision medicine for corticotherapy in COVID-19.
    Intensive Care Med. 2022 Jun 22. pii: 10.1007/s00134-022-06751.
    PubMed    
    
    
    
91. TORRES A, Motos A, Cilloniz C, Ceccato A, et al
    Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
    Intensive Care Med. 2022 Jun 21. pii: 10.1007/s00134-022-06726.
    PubMed     Abstract available
    
    
    
92. STEINBERG I, Chiodaroli E, Gattarello S, Cappio Borlino S, et al
    Diaphragmatic ultrasound and esophageal pressure in COVID-19 pneumonia during helmet CPAP.
    Intensive Care Med. 2022 Jun 21. pii: 10.1007/s00134-022-06785.
    PubMed    
    
    
    
93. LABRO G, Tubach F, Belin L, Dubost JL, et al
    Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial.
    Intensive Care Med. 2022 Jun 9. pii: 10.1007/s00134-022-06721.
    PubMed     Abstract available
    
    
    
94. VIEILLARD-BARON A, Huang S
    Characterising right ventricular dysfunction in COVID-19 ARDS: which measurements are the best? Author's reply.
    Intensive Care Med. 2022 Jun 9. pii: 10.1007/s00134-022-06774.
    PubMed    
    
    
    
95. MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
    Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.
    Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
    PubMed    
    
    
    May 2022
96. GRECO M, De Corte T, Ercole A, Antonelli M, et al
    Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study.
    Intensive Care Med. 2022 May 21. pii: 10.1007/s00134-022-06705.
    PubMed     Abstract available
    
    
    
97. CHOTALIA M, Patel J, Parekh D, Bangash M, et al
    Characterising right ventricular dysfunction in acute respiratory distress syndrome due to COVID-19: which measurements are best?
    Intensive Care Med. 2022 May 20. pii: 10.1007/s00134-022-06742.
    PubMed    
    
    
    
98. GATTO I, Biagioni E, Coloretti I, Farinelli C, et al
    Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
    Intensive Care Med. 2022 May 18. pii: 10.1007/s00134-022-06716.
    PubMed     Abstract available
    
    
    
99. WHEBELL S, Zhang J, Lewis R, Berry M, et al
    The need to define "who" rather than "if" for ECMO in COVID-19.
    Intensive Care Med. 2022 May 17. pii: 10.1007/s00134-022-06732.
    PubMed    
    
    
    
100. EVRARD B, Goudelin M, Giraudeau B, Francois B, et al
     Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening.
     Intensive Care Med. 2022 May 12. pii: 10.1007/s00134-022-06730.
     PubMed    
     
     
     
101. HJORTRUP PB, Butt W
     Cardiac manifestations in critically ill patients with COVID-19: do we really know what hit us?
     Intensive Care Med. 2022 May 10. pii: 10.1007/s00134-022-06727.
     PubMed    
     
     
     April 2022
102. WATANABE A
     Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect.
     Intensive Care Med. 2022 Apr 22. pii: 10.1007/s00134-022-06711.
     PubMed    
     
     
     
103. HUANG S, Vignon P, Mekontso-Dessap A, Tran S, et al
     Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study).
     Intensive Care Med. 2022 Apr 21. pii: 10.1007/s00134-022-06685.
     PubMed     Abstract available
     
     
     
104. SPOELDER EJ, Lerou J, Bronkhorst E, van Geffen GJ, et al
     Time course of physiological variables during inter-hospital helicopter transport of ventilated COVID-19 patients.
     Intensive Care Med. 2022 Apr 12. pii: 10.1007/s00134-022-06686.
     PubMed    
     
     
     
105. BEST JR, Wang M, Lee T, Russell JA, et al
     Early increases in anti-SARS-CoV-2 antibody isotypes associated with organ dysfunction and mortality in patients hospitalized with COVID-19.
     Intensive Care Med. 2022 Apr 2. pii: 10.1007/s00134-022-06662.
     PubMed    
     
     
     March 2022
106. GRANHOLM A, Kjaer MN, Munch MW, Myatra SN, et al
     Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
     Intensive Care Med. 2022 Mar 31. pii: 10.1007/s00134-022-06677.
     PubMed     Abstract available
     
     
     
107. GUIDET B, Jung C, Flaatten H, Fjolner J, et al
     Correction to: Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19.
     Intensive Care Med. 2022 Mar 31. pii: 10.1007/s00134-022-06674.
     PubMed    
     
     
     
108. TAN MZY
     Critical but stable-critical care communication in the COVID-19 pandemic*.
     Intensive Care Med. 2022 Mar 28. pii: 10.1007/s00134-022-06675.
     PubMed    
     
     
     
109. BUIL JB, Schouten JA, Wauters J, van de Hoeven H, et al
     Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination.
     Intensive Care Med. 2022 Mar 22. pii: 10.1007/s00134-022-06651.
     PubMed    
     
     
     
110. WHEBELL S, Zhang J, Lewis R, Berry M, et al
     Correction to: Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.
     Intensive Care Med. 2022 Mar 18. pii: 10.1007/s00134-022-06681.
     PubMed    
     
     
     
111. URBINA T, Chauvet M, Lacombe K, Maury E, et al
     COVID-19-associated Multi-Inflammatory Syndrome in Adults (MIS-A): look into the eyes!
     Intensive Care Med. 2022 Mar 14. pii: 10.1007/s00134-022-06667.
     PubMed    
     
     
     
112. VAN GENDEREN ME, van Uitert E, Duvekot JJ, Gommers D, et al
     Management and outcome of critically ill pregnant women with COVID-19.
     Intensive Care Med. 2022 Mar 14. pii: 10.1007/s00134-022-06653.
     PubMed    
     
     
     
113. WHEBELL S, Zhang J, Lewis R, Berry M, et al
     Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.
     Intensive Care Med. 2022 Mar 3. pii: 10.1007/s00134-022-06645.
     PubMed     Abstract available
     
     
     February 2022
114. GUIDET B, Jung C, Flaatten H, Fjolner J, et al
     Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19.
     Intensive Care Med. 2022 Feb 26. pii: 10.1007/s00134-022-06642.
     PubMed     Abstract available
     
     
     
115. SCHALLER SJ, Mellinghoff J, Cecconi M
     Education to save lives: C19SPACE, the COVID19 Skills PrepAration CoursE.
     Intensive Care Med. 2022;48:227-230.
     PubMed    
     
     
     January 2022
116. SINGH A, Soni KD, Venkateswaran V, Trikha A, et al
     Paranephric air in COVID-ARDS patient: an extension of pneumothorax.
     Intensive Care Med. 2022;48:118.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.